. Shabir Ahmad Dar; . Mohammad Maqbool Dar; . Shanoo Sheikh; . Inaamul Haq; . Aaliya Mohi Ud Din Azad; . Mehvish Mushtaq; . Naveed Nazir Shah; . Zaid Ahmad Wani
Volume 11, Issue 7 , August 2021, , Pages 1-9
Abstract
BACKGROUND: The coronavirus disease‑19 (COVID‑19) emerged from China and rapidly spreadto many other countries all over the world. This study aimed to assess the prevalence of anxiety,depression, ...
Read More
BACKGROUND: The coronavirus disease‑19 (COVID‑19) emerged from China and rapidly spreadto many other countries all over the world. This study aimed to assess the prevalence of anxiety,depression, posttraumatic stress disorder, and obsessive–compulsive (OC) symptoms amongCOVID‑19 survivors after their discharge from the COVID‑19 treatment center.MATERIALS AND METHODS: This was a cross‑sectional, hospital‑based study performed among119 COVID‑19 survivors. The Hospital Anxiety and Depression Scale (HADS) was used to measureanxiety and depression. Posttraumatic Stress Disorder (PTSD)‑Checklist (PCL) and Brief OC Scalewere used to measure PTSD and OC symptoms. Data were analyzed by descriptive and inferentialstatistics using the SPSS (IBM Corp. Released 2015 version 23.0).RESULTS: The mean anxiety, depression, and PTSD scores were, 7.12 ± 0.68, 8.08 ± 0.22, and19.78 ± 0.88, respectively. Based on cutoff scores, the prevalence of anxiety, depression, andPTSD among COVID‑19 survivors was n = 53, 44.54%; n = 73, 61.34%; and n = 30, 25.21%,respectively. Older COVID‑19 survivors (≥50 years) were more likely to show symptoms ofdepression and anxiety (P < 0.001) compared to younger ones. Furthermore, COVID‑19 survivorswho were ≥50 years of age experienced a greater level of PTSD compared to younger ones; similartrends were seen in those experiencing OC symptoms. In the present study, n = 98 (82.4%) wereobsessed with fears of contamination and an equal number had compulsive handwashing.CONCLUSION: Anxiety, depression, PTSD, and OC symptoms are common among the COVID‑19survivors and that underscores the need to diagnose and manage mental health morbidities amongthese survivors long after their recovery from COVID‑19.